Controlled Active Motion vs Early Passive Mobilization for Flexor Tendons Repair
Launched by UNIVERSITY OF HAIL · May 14, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to help people recover after surgery to repair a flexor tendon in their finger. The two methods being tested are called Early Passive Mobilization (EPM), where the finger is gently moved without using its own strength, and Controlled Active Motion (CAM), where the patient actively moves their finger in a controlled way. The goal of the study is to see which approach helps people heal better and regain movement in their fingers after surgery.
To take part in this trial, you need to be between 25 and 50 years old and have recently had surgery to repair a tendon in one of your fingers, specifically the flexor tendons that help you bend your fingers. Unfortunately, if you have certain health issues that affect your hand joints, or if your injury is more complicated, you won't be able to join. If you participate, you can expect to follow a specific rehabilitation program and receive regular check-ups to monitor your recovery. This study is currently looking for participants, so if you or someone you know is eligible, this could be a good opportunity to help improve recovery methods for tendon injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • males or females
- • between 25-50 years
- • Post-surgical repair of the flexor digitorum profundus (FDP) and superficialis (FDS) tendons of a single-digit
- • the case should be recent (2-3 days post-surgical)
- Exclusion Criteria:
- • age below 25 or above 50
- • a systemic disease affecting hand joints such as rheumatic arthritis
- • thumb flexor tendon repair will be excluded
- • chronic cases
- • concurrent injuries such as phalangeal fractures, joint injuries, or significant skin loss
About University Of Hail
The University of Hail is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to improving patient outcomes and enhancing medical knowledge, the university fosters interdisciplinary collaboration among experts in various fields, including medicine, pharmacology, and public health. By conducting rigorous clinical trials, the University of Hail aims to translate scientific discoveries into practical solutions that address pressing health challenges, while ensuring the highest standards of ethical conduct and participant safety. With a focus on community engagement and knowledge dissemination, the university plays a pivotal role in shaping the future of healthcare in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hail, , Saudi Arabia
Hail, , Saudi Arabia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0